Benchling Introduces AI Platform to Accelerate Scientific Research

Benchling, provider of a cloud-based platform for biotechnology research and development, has launched Benchling AI, a suite of generative and predictive tools built to streamline scientific workflows across drug discovery, biomanufacturing, and genomics. The platform integrates directly with Benchling’s cloud-based data system, enabling researchers to query experiments in natural language, generate molecular annotations, and surface insights from structured and unstructured datasets. Benchling CEO Sajith Wickramasekara stated, "The goal is to put AI in the hands of every scientist and bend the speed and cost curve of making medicines." Benchling AI features agents, including the Deep Research Agent, Data Entry Agent, and Compose Agent, enabling scientists to access models in one place for optimized experiments. 

The launch comes amid growing investment in AI for scientific research. Benchling claims its advantage lies in its integration with existing lab workflows, providing scientists with AI assistance within the data platforms they already use. A top 20 biopharma company has already utilized Benchling’s Deep Research Agent, reducing project length by eight months.

Posted by MedCloudInsider Editors on 10/07/2025